Cinclus Pharma Holding AB (publ) (STO:CINPHA)
Sweden · Delayed Price · Currency is SEK 12.22
+0.06 (0.49%)
At close: Jun 15, 2026
Cinclus Pharma Holding AB Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Cinclus Pharma Holding AB stock has a consensus rating of "Strong Buy" and an average price target of kr 46.25. The average 1-year stock price forecast is 278.48% higher than the current stock price, while the lowest is kr 25.00 (+104.58%) and the highest is kr 70.00 (+472.83%).
Price Target: kr 46.25 (+278.48%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Cinclus Pharma Holding AB stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 3 | 3 | 3 |
Financial Forecast
Revenue This Year
93.63M
from 57.47M
Increased by 62.91%
Revenue Next Year
117.33M
from 93.63M
Increased by 25.31%
EPS This Year
-6.03
EPS Next Year
-5.65
from -6.03
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SEK.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 118.6M | ||
| Avg | 93.6M | ||
| Low | 67.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 106.4% | ||
| Avg | 62.9% | ||
| Low | 16.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -4.88 | ||
| Avg | -6.03 | ||
| Low | -7.17 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |